《瑞信窩輪》小米捱沽藥明回購,留意小米牛68463、藥明牛59773
小米(1810)發佈小米12系列手機後,不過大市受壓,股價週三亦低走逾2%,曾經失守18.4元。向上19元或已建成阻力,支持或參考18元。看好可留意小米購15493,行使價19.82元,22年4月到期。或小米牛68463,收回價17.18元,行使價16.78元,22年5月到期。相反看淡可留意小米沽19635,行使價14.98元,22年6月到期。或小米熊54136,收回價19.88元,行使價20.28元,22年7月到期。
芯片股中芯國際(0981)逆市靠穩,高位曾觸及18.6元水平。看好可留意中芯購18876,行使價20.88元,22年6月到期。或中芯牛59396,收回價16.88元,行使價15.88元,22年10月到期。相反看淡可留意中芯熊59730,收回價20.00元,行使價21.00元,22年7月到期。
手機設備股舜宇光學(2382)方向未明,徘徊在240元以上。向上阻力留意週三高位258元,支持或參考230元。看好可留意舜光購27873,行使價260.20元,22年2月到期。或舜光牛53426,收回價221.00元,行使價217.00元,22年7月到期。相反看淡可留意舜光沽19430,行使價198.78元,22年6月到期。或舜光熊53082,收回價265.00元,行使價269.00元,22年2月到期。
藥明生物(2269)公佈週二回購約225萬股,不過週三曾挫近4%,回落至86元以下。向下或觀望能否在80元水平建立支持,向上阻力參考90元關。看好可留意藥明購12382,行使價96.88元,22年6月到期。或藥明牛59773,收回價78.00元,行使價76.00元,22年7月到期。相反看淡則可留意藥明熊59781,收回價94.88元,行使價96.88元,22年7月到期。
以上產品資料來源: 彭博資訊及瑞信網站cswarrants.com
(本結構性產品並無抵押品)
《瑞信香港認股證及牛熊證銷售主管何啓聰》
免責聲明:筆者爲瑞士信貸(香港)有限公司的代表 ,並身爲證監會持牌人,並無持有相關上市公司的任何財務權益。本文內容僅供參考,並不構成要約、建議或促使任何人士提呈買賣或認購任何證券。結構性產品價格可急升或急跌,投資者或會蒙受全盤損失。本產品並無抵押品。如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。牛熊證備強制贖回機制而可能被提早終止,屆時(i)N類牛熊證投資者將不獲發任何金額;而(ii)R類牛熊證之剩餘價值可能爲零。有關恆生指數,恆生中國企業指數或恆生科技指數的免責聲明,請參閱上市文件。有關納斯達克100指數的免責聲明,請參閱上市文件。過往表現並不反映將來表現。投資前,投資者應瞭解風險,並諮詢專業顧問及查閱有關上市文件。瑞信之聯屬公司Credit Suisse Securities (Hong Kong) Limited爲結構性產品之流通量提供者,亦可能是唯一報價者。本文任何內容概不構成投資、法律、會計或稅務意見、並無聲明任何投資或策略適合或符合閣下的個別情況。結構性產品交投量並不是結構性產品表現的指標,投資者不應僅依賴交投量歷史高位數據以釐定結構性產品日後的表現。~
重要聲明:
以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.